The ERS Congress
The European Respiratory Society (ERS) Congress is the world's biggest annual scientific gathering in respiratory medicine.
Lung cancer
Upper Gastrointestinal Tract Endoscopic Ultrasound
Endoscopic ultrasound (EUS) is the combination of ultrasound and endoscopy, which allows placement of high-frequency transducers close to the intestinal wall and adjacent structures. As EUS enters its third decade, it is used for locoregional staging of many upper gastrointestinal malignancies, including cancers of the oesophagus, stomach, duodenum, ampulla of Vater, extrahepatic bile ducts and…
Multi-slice Helical CT Scanning of the Chest
Lung cancer is the main cause of deaths due to cancer in human males and the incidence is constantly increasing. A cure rate of only 10% has been reported because most neoplastic lesions are diagnosed too late. However, when lung cancer is diagnosed early and surgical resection performed (stage 1 cancer), 5-year survival is significantly improved and may reach 70%.
Study shows relation between LKB1 gene and lung cancer
Lung cancer has a high mortality: Despite prevention programms each year 1.3 million people die due to malignant mutation of lung cells. It's the most common cause of cancer-related death in men, second most common in women.
Ultra Low Dose CT of the Lungs
Excluding pulmonary coin lesions potentially caused by metastasis of extrathoracic malignant tumours or as the principal indication of early lung carcinomas is one of the most frequent tasks in plain film imaging and computed tomography examination of the thorax.
In-vivo and in-vitro diagnostics in molecular medicine
In molecular medicine - and particularly in oncology - Siemens Medical Solutions is concentrating on further development of the FDG (fluorodeoxyglucose) biomarker to improve identification of certain tumours.
Visualising the breathing lung
After previous meetings in the USA (2002) and Japan (2004), this October the 3rd International Workshop of Pulmonary Functional Imaging (IWPFI) took place in the German Cancer Research Centre, based in Heidelberg University, Germany. " 'The clinicians' need for earlier and more detailed diagnosis in pulmonary disease demands a joint interdisciplinary effort to push the limits in pulmonary…
Ground Zero
Workers suffer long-term health effects five years after World Trade Center terrorist attacks.
New Cancer Drug Hope
AstraZeneca has been collaborating with researchers who detected a potential Aurora B inhibitor.
The Lancet highlights cardiac research
Among the research articles published in this issue, are some ...
Todays treatments
Dr Christiane Eickelberg, of the University of Giessen Lung Centre (UGLC), outlines the centre's research projects, aims and academic offerings
Respiratory diseases
From burden to therapy. By Andrea Rossi MD, Director of the Respiratory Division at Bergamo General Hospital Bergamo, Italy, and Chair of the Scientific Committee of the European Respiratory Society
Small wireless device to improve cancer treatment
USA - Engineers are developing a tiny wireless device - the size of a rice grain - to be implanted in tumours to indicate the precise radiation dose received and to locate the exact position of tumours during treatment.
The UK's National Lung Cancer Forum for Nurses
With increasing numbers of nurses specialising the care of lung cancer patients, The National Lung Cancer Forum for Nurses (NLCFN) was established in 1997 to offer them a network for information exchange and to support nurses working in 'isolation' due to their changing and different roles.
Alcohol ups colon cancer risk
Denmark - Regular drinkers significantly increase their risk of rectal cancer, but that risk is reduced if wine makes up a third or more of weekly consumption, according to research carried out by Professor Morten Grønbaek, at the Centre for Alcohol Research, National Institute of Public Health, Copenhagen, published in the journal GUT.
Article • Research, diagnostics, treatments
Focus on lung cancer
Lung cancer (pulmonary carcinoma) is one of the most common cancers worldwide and the leading cause of cancer-related deaths globally. The diagnostic and therapeutic options for lung cancer have expanded significantly in recent years. Keep reading for latest developments in screening, biomarker testing, treatment innovations, and ongoing research.
